发明名称 USE OF TESTOSTERONE AND 5-HT1A AGONIST FOR TREATING SEX MALFUNCTION
摘要 PROBLEM TO BE SOLVED: To provide a therapeutic agent for the sex malfunction of a man and/or a woman.SOLUTION: Provided is use of testosterone and 5-HT1A agonist in the preparation of a medicine for treating sex malfunction, in which the 5-HT1A is discharged essentially 1 hour before sexual intercourse, and the testosterone is released 3.5 to 5.5 hours before sexual intercourse. Further, in the use, the sexual malfunction being for a man or a woman. Provided is also a pharmaceutical composition comprising: testosterone; a PDE5 inhibitor; and a 5-HT1A agonist, and the preparation thereof is designed in such a manner that the 5-HT1A is discharged essentially 1 hour before sexual intercourse, the PDE5 inhibitor is discharged 1-2 hours before sexual intercourse, and also the testosterone is discharged 3.5 to 5.5 hours before sexual intercourse.
申请公布号 JP2015157849(A) 申请公布日期 2015.09.03
申请号 JP20150094573 申请日期 2015.05.07
申请人 EB IP LYBRIDOS BV 发明人 TUITEN JEAN JOAN ADRIAN;BLOEMERS JOHANNES MARTINUS MARIA;DE LANGE ROBERTUS PETRUS JOHANNES
分类号 A61K31/568;A61K31/496;A61K31/519;A61K45/00;A61P5/26;A61P15/08;A61P15/10;A61P43/00 主分类号 A61K31/568
代理机构 代理人
主权项
地址